NCCM
AEGR

Nine Chapters Capital Management’s Aegerion Pharmaceuticals AEGR Stock Holding History

Nine Chapters Capital Management’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-104,600
Closed -$1.98M – 1308
2015
Q2 		$1.98M Buy
104,600
+77,200
+282% +$1.67M 0.17% 165
2015
Q1 		$717K Buy
+27,400
New +$697K 0.06% 465
2014
Q4 		– Sell
-7,700
Closed -$257K – 1329
2014
Q3 		$257K Buy
+7,700
New +$239K 0.02% 768
2014
Q1 		– Sell
-5,800
Closed -$412K – 1051
2013
Q4 		$412K Sell
5,800
-3,000
-34% -$229K 0.04% 535
2013
Q3 		$755K Buy
+8,800
New +$746K 0.09% 314

Other funds holding AEGR

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nine Chapters Capital Management's AEGR Position: Q3 2015 in Review

Nine Chapters Capital Management sold out of Aegerion Pharmaceuticals (AEGR) in Q3 2015, closing a stake of 104,600 shares — an estimated $1.98M sold.

Nine Chapters Capital Management first reported a position in AEGR in Q3 2013 and held it in 5 quarters. The position peaked at $1.98M in Q2 2015. 96 funds tracked by Wall St. Rank hold AEGR as of Q3 2015.

  • Nine Chapters Capital Management reported no remaining Aegerion Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Nine Chapters Capital Management sold 104,600 Aegerion Pharmaceuticals shares in Q3 2015, an estimated $1.98M.
  • Nine Chapters Capital Management first reported a position in Aegerion Pharmaceuticals in Q3 2013 and held it in 5 quarters.
  • Nine Chapters Capital Management's Aegerion Pharmaceuticals position peaked at $1.98M in Q2 2015.
  • 96 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q3 2015.

Based on Nine Chapters Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.